glp-1 obesity drug news october 21 2025 New Pill Foundayo (Orforglipron) Gets FDA Approval for Lilly orforglipron oral GLP-1 phase

Practical Considerations in Diabetes Care When considering GLP1 therapy in patients with diabetes who also consume alcohol, clinicians should balance potential metabolic and weight benefits with individual patient goals and risks

Algunos practicantes recomiendan inyecciones nocturnas para pacientes usando BPC-157 principalmente para recuperacin y reparacin de tejidos durante el sueo

2025;doi:10.1001/jamainternmed.2025.1109

Your body already produces this compound

And because CJC-1295 works by stimulating your body's production of human growth hormone, which naturally declines with age, it can sound like a compelling option for women in midlife when symptoms like muscle loss, belly fat, and disrupted sleep are already top of mind

Guilt, shame, and isolation surround weight management for so many people